Reduced male fertility in childhood cancer survivors
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
With advances in cancer treatment, more pediatric cancer patients have increased their life expectancy. Because cancer-related therapy causes various physical and psychological problems, many male survivors experience later problems with thyroid and sexual functions, and with growth. As outcomes have improved, more survivors need to maintain their reproductive function to maximize their long-term quality of life. Cancer and cancer-related treatment can impair fertility by damage to the testes,to the hypothalamic-pituitary-gonadal axis, or to the genitourinary organs. Prior radiation therapy to the testes, the use of alkylating agents, and central hypogonadism further impair fertility in male survivors of childhood cancer. Following any course of chemotherapy, peripubertal maturation, any testicular volume changes, and symptoms of androgen deficiency should be monitored systematically. If patients request fertility testing, spermatogenesis status can be evaluated either directly by semen analysis or indirectly by determination of the levels of testosterone/gonadotropins and by monitoring any changes in testicular volume. According to the patient's condition,semen cryopreservation, hormonal therapy, or assisted reproduction technologies should be provided.
Abstract
With advances in cancer treatment, more pediatric cancer patients have increased their life expectancy. Because cancer-related therapy causes various physical and psychological problems, many male survivors experience later problems with thyroid and sexual functions, and with growth. As outcomes have improved, more survivors need to maintain their reproductive function to maximize their long-term quality of life. Cancer and cancer-related treatment can impair fertility by damage to the testes,to the hypothalamic-pituitary-gonadal axis, or to the genitourinary organs. Prior radiation therapy to the testes, the use of alkylating agents, and central hypogonadism further impair fertility in male survivors of childhood cancer. Following any course of chemotherapy, peripubertal maturation, any testicular volume changes, and symptoms of androgen deficiency should be monitored systematically. If patients request fertility testing, spermatogenesis status can be evaluated either directly by semen analysis or indirectly by determination of the levels of testosterone/gonadotropins and by monitoring any changes in testicular volume. According to the patient's condition,semen cryopreservation, hormonal therapy, or assisted reproduction technologies should be provided.
참고문헌 (36)
- Annual report of cancer incidence (2005) and survival (1993-2005) in Korea, "Ministry for Health, Welfare, and Family Affairs", Ministry for Health, Welfare, and Family Affairs, 98~ (2008)
- 유철주, "Increasing and Worsening Late Effects in Childhood Cancer Survivors during Follow-up", Journal of Korean Medical Science, 28(5), pp.755~762 (2013), 대한의학회
- Jeruss JS, "Preservation of fertility in patients with cancer", N Engl J Med, 360, pp.902~911 (2009)
- Darzy KH, "Hypopituitarism following radiotherapy revisited", Endocr Dev, 15, pp.1~24 (2009)
- Meistrich ML, "Effects of chemotherapy and radiotherapy on spermatogenesis in humans", Fertil Steril, 100, pp.1180~1186 (2013)
- Green DM, "Fertility of male survivors of childhood cancer: a report from the Childhood Cancer Survivor Study", J Clin Oncol, 28, pp.332~339 (2010)
- Meistrich ML, "Rapid recovery of spermatogenesis after mitoxantrone, vincristine, vinblastine, and prednisone chemotherapy for Hodgkin's disease", J Clin Oncol, 15, pp.3488~3495 (1997)
- da Cunha MF, "Temporary effects of AMSA (4'- (9-acridinylamino) methanesulfon-m-anisidide) chemotherapy on spermatogenesis", Cancer, 49, pp.2459~2462 (1982)
- Buchanan JD, "Return of spermatogenesis after stopping cyclophosphamide therapy", Lancet, 2, pp.156~157 (1975)
- Kenney LB, "High risk of infertility and long term gonadal damage in males treated with high dose cyclophosphamide for sarcoma during childhood", Cancer, 91, pp.613~621 (2001)
- da Cunha MF, "Recovery of spermatogenesis after treatment for Hodgkin's disease: limiting dose of MOPP chemotherapy", J Clin Oncol, 2, pp.571~577 (1984)
- Jacob A, "Recovery of spermatogenesis following bone marrow transplantation", Bone Marrow Transplant, 22, pp.277~279 (1998)
- Hansen PV, "Testicular function in patients with testicular cancer treated with orchiectomy alone or orchiectomy plus cisplatin-based chemotherapy", J Natl Cancer Inst, 81, pp.1246~1250 (1989)
- Sanders JE, "Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation", Blood, 87, pp.3045~3052 (1996)
- Marina S, "Permanentsterilit yafter immunosuppressive therapy", Int J Androl, 2, pp.6~13 (1979)
- Wyns C, "Options for fertility preservation in prepubertal boys", Hum Reprod Update, 16, pp.312~328 (2010)
- Kenney LB, "Male reproductive health after childhood, adolescent, and young adult cancers: a report from the Children's Oncology Group", J Clin Oncol, 30, pp.3408~3416 (2012)
- Rowley MJ, "Effect of graded doses of ionizing radiation on the human testis", Radiat Res, 59, pp.665~678 (1974)
- Ogilvy-Stuart AL, "Effect of radiation on the human reproductive system", Environ Health Perspect, 101(2), pp.109~116 (1993)
- Howell SJ, "Spermatogenesis after cancer treatment: damage and recovery", J Natl Cancer Inst Monogr, (34), pp.12~17 (2005)
- Ash P., "The influence of radiation on fertility in man", Br J Radiol, 53, pp.271~278 (1980)
- Meistrich ML, "Male gonadal toxicity", Pediatr Blood Cancer, 53, pp.261~266 (2009)
- Shalet SM, "Vulnerability of the human Leydig cell to radiation damage is dependent upon age", J Endocrinol, 120, pp.161~165 (1989)
- World Health Organization, "WHO laboratory manual for the examination and processing of human semen" (2010), WHO Press
- Cooper TG, "World Health Organization reference values for human semen characteristics", Hum Reprod Update, 16, pp.231~245 (2010)
- Guzick DS, "Sperm morphology, motility, and concentration in fertile and infertile men", N Engl J Med, 345, pp.1388~1393 (2001)
- Male Infertility Best Practice Policy Committee of the American Urological Association, "Report on optimal evaluation of the infertile male", Fertil Steril, 86(5 Suppl 1), pp.S202~S209 (2006)
- Rendtorff R, "Low inhibin B levels alone are not a reliable marker of dysfunctional spermatogenesis in childhood cancer survivors", Andrologia, 44(1), pp.219~225 (2012)
- Petak SM, "American Association of Clinical Endocrinologists. American Association of Clinical Endocrinologists Medical Guidelines for clinical practice for the evaluation and treatment of hypogonadism in adult male patients--2002 update", Endocr Pract, 8, pp.440~456 (2002)
- Lopez Andreu JA, "Persistent altered spermatogenesis in long-term childhood cancer survivors", Pediatr Hematol Oncol, 17, pp.21~30 (2000)
- Han TS, "What is the optimal therapy for young males with hypogonadotropic hypogonadism?", Clin Endocrinol (Oxf), 72, pp.731~737 (2010)
- Ginsberg JP, "Sperm banking for adolescent and young adult cancer patients: sperm quality, patient, and parent perspectives", Pediatr Blood Cancer, 50, pp.594~598 (2008)
- Feldschuh J, "Successful sperm storage for 28 years", Fertil Steril, 84, pp.1017~ (2005)
- Neal MS, "Effectiveness of sperm banking in adolescents and young adults with cancer: a regional experience", Cancer, 110, pp.1125~1129 (2007)
- Schwarzer JU, "Sperm retrieval procedures and intracytoplasmatic spermatozoa injection with epididymal and testicular sperms", Urol Int, 70, pp.119~123 (2003)
- Hsiao W, "Successful treatment of postchemotherapy azoospermia with microsurgical testicular sperm extraction: the Weill Cornell experience", J Clin Oncol, 29, pp.1607~1611 (2011)